Stableford Capital II LLC Takes Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Stableford Capital II LLC has acquired a new stake in Intuitive Surgical, purchasing 1,863 shares valued at approximately $924,000 during the second quarter.
• Institutional investors own 83.64% of Intuitive Surgical's stock, indicating strong interest from hedge funds as several others increased their stakes recently.
• Analysts have mixed ratings for Intuitive Surgical, with a consensus target price of $582.14, and recent price targets range from $520.00 to $595.00.

Stableford Capital II LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,863 shares of the medical equipment provider's stock, valued at approximately $924,000.

Other hedge funds have also bought and sold shares of the company. Chilton Capital Management LLC lifted its stake in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new stake in Intuitive Surgical in the 1st quarter valued at about $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical in the 1st quarter valued at about $30,000. TD Capital Management LLC lifted its stake in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in Intuitive Surgical during the first quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have issued reports on ISRG shares. Piper Sandler restated an "overweight" rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Mizuho cut their price objective on shares of Intuitive Surgical from $570.00 to $520.00 and set a "neutral" rating for the company in a research report on Tuesday. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, October 4th. Zacks Research downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $582.14.

Intuitive Surgical Trading Down 0.2%

NASDAQ ISRG opened at $435.61 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a 50 day moving average of $456.15 and a 200-day moving average of $496.60. The company has a market cap of $156.16 billion, a price-to-earnings ratio of 60.75, a PEG ratio of 4.58 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the business earned $1.78 earnings per share. The firm's quarterly revenue was up 21.4% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares of the company's stock, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 over the last three months. 0.70% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.